High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants - Is prevention failing?

Substance Use and Misuse

Volumn 51, Issue 2, 2016, Pages 250-260

  Folch, Cinta ^a,b,c   Casabona, Jordi ^a,b,c,d   Espelt, Albert ^b,d,e   Majó, Xavier ^a   Meroño, Mercè ^f   Gonzalez, Victoria ^a,b,g   Wiessing, Lucas ^h   Colom, Joan ^a   Brugal, M Teresa ^b,e  

^a GENERALITAT DE CATALUNYA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c IrsiCaixa Aids Research Institute   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^f Àmbit Prevenció Foundation Ciutat Vella District   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

Hepatitis C; HIV, injecting drug use; migrants; new injectors

Indexed keywords

ADULT; AGE; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; FEMALE; HARM REDUCTION; HEPATITIS C; HIGH RISK BEHAVIOR; HIV INFECTIONS; HOMELESS PERSON; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MIGRANT; NEEDLE SHARING; POISSON DISTRIBUTION; PREVALENCE; PROSTITUTION; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SPAIN; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TIME FACTOR; YOUNG ADULT;

ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; EMIGRANTS AND IMMIGRANTS; FEMALE; HARM REDUCTION; HEPATITIS C; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEEDLE SHARING; POISSON DISTRIBUTION; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; RISK-TAKING; SEX WORK; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 84959511835     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2015.1092991     Document Type: Article

References (43)

1. Bailey, S. L., Ouellet, L. J., Mackesy-Amiti, M. E., Golub, E. T., Hagan, H., Hudson, S. M.,. DUIT Study Team. (. 2007). Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug and Alcohol Dependance, 91 (1), S18-29
2. Barrio, G., Bravo, M. J., Brugal, M. T., Diez, M., Regidor, E., Belza, M. J.,. Itinere Working Group. (. 2012). Harm reduction interventions for drug injectors or heroin users in Spain: Expanding coverage as the storm abates. Addiction, 107 (6), 1111-1122
3. Barros, A. J. D., & Hirakata, V. N. (. 2003). Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology, 3, 21
4. Becker Buxton, M., Vlahov, D., Strathdee, S. A., Des Jarlais, D. C., Morse, E. V., Ouellet, L.,. Garfein, R. S. (. 2004). Association between injection practices and duration of injection among recently initiated injection drug users. Drug and Alcohol Dependence, 75 (2), 177-183
5. Bravo, M. J., Vallejo, F., Barrio, G., Brugal, M. T., Molist, G., Pulido, J.,. Itinere Working Group. (. 2012). HCV seroconversion among never-injecting heroin users at baseline: No predictors identified other than starting injection. The International Journal on Drug Policy, 23 (5), 415-419
6. Centre dEstudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). (. 2013). Integrated surveillance of HIV/AIDS/STI Catalonia (SIVES 2012). (Technical Document 21). Barcelona: Generalitat de Catalunya, Agència de Salut Pública de Catalunya. Retrieved from. http://www.ceeiscat.cat/documents/SIVES-2012.pdf
7. Chohan, B. H., Lavreys, L., Mandaliya, K. N., Kreiss, J. K., Bwayo, J. J., Ndinya-Achola, J. O., & Martin H. L., Jr. (. 2001). Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva. Clinical and Diagnostic Laboratory Immunology, 8 (2), 346-348
8. De la Fuente, L., Bravo, M. J., Toro, C., Brugal, M. T., Barrio, G., Soriano, V.,. Itinere Working Group. (. 2006). Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. Journal of Epidemiology and Community Health, 60 (6), 537-542
9. Dietze, P., Winter, R., Pedrana, A., Leicht, A., Majó, X., & Brugal, M.T. (. 2012). Mobile safe injecting facilities in barcelona and Berlin. International Journal of Drug Policy, 23, 257-260
10. Drobnik, A., Judd, C., Banach, D., Egger, J., Konty, K., & Rude, E. (. 2011). Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. American Journal of Public Health, 101 (11), 2151-2155
11. European Monitoring Center for Drugs and Drug Addiction (EMCDDA). (. 2012). Annual Report 2012: The State of the Drugs Problem in Europe. Luxembourg: Publications Office of the European Union
12. Folch, C., Casabona, J., Espelt, A., Majo, X., Merono, M., Gonzalez, V.,. REDAN Study Group. (. 2013). Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain. Gaceta Sanitaria/S.E.S.P.A.S, 27 (4), 338-343
13. Freixa, P., & Merono, M. (2011). Estudi qualitatiu sobre usuaris de drogues per via parenteral provinents d'Europa de l'Est a Catalunya. Barcelona, Spain: Àmbit Prevenció.
14. Friedman, S.R., Rossi, D., & Braine, N. (. 2009). Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. International Journal of Drug Policy, 20, 283-91
15. Garten, R. J., Lai, S., Zhang, J., Liu, W., Chen, J., Vlahov, D., & Yu, X. F. (. 2004). Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology, 33 (1), 182-188
16. Goldstein, M. F., Friedman, S. R., Neaigus, A., Jose, B., Ildefonso, G., & Curtis, R. (. 1995). Self-reports of HIV risk behavior by injecting drug users: Are they reliable ? Addiction, 90 (8), 1097-1104
17. Hacker, M. A., Friedman, S. R., Telles, P. R., Teixeira, S. L., Bongertz, V., Morgado, M. G., & Bastos, F. I. (. 2005). The role of "long-Term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Substance Use & Misuse, 40 (1), 99-123
18. Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (. 2008). Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place. American Journal of Epidemiology, 168 (10), 1099-1109
19. Hagan, H., Pouget, E. R., Williams, I. T., Garfein, R. L., Strathdee, S. A., Hudson, S. M.,. Ouellet, L. J. (2010). Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. Journal of Infectious Diseases, 201 (3), 378-385
20. Harocopos, A., Goldsamt, L. A., Kobrak, P., Jost, J. J., & Clatts, M. C. (. 2009). New injectors and the social context of injection initiation. The International Journal on Drug Policy, 20, 317-323
21. Huntington, S., Folch, C., Gonzalez, V., Meroño, M., Ncube, F., & Casabona, J. (. 2010). Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia. Enfermedades Infecciosas y Microbiologia Clinica, 28 (4), 236-238
22. Jones, L., Pickering, L., Sumnall, H., McVeigh, J., & Bellis, M. A. (. 2010). Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. International Journal of Drug Policy, 21 (5), 335-342
23. Judd, A., Hickman, M., Jones, S., McDonald, T., Parry, J. V., Stimson, G. V., & Hall, A. J. (. 2005). Incidence of hepatitis C virus and HIV among new injecting drug users in London: Prospective cohort study. British Medical Journal, 330 (7481), 24-25
24. Judd, A., Parry, J., Hickman, M., McDonald, T., Jordan, L., Lewis, K.,. Nelson, M. (. 2003). Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. Journal of Medical Virology, 71 (1), 49-55
25. Magura, S., Nwakeze, P. C., Rosenblum, A., & Joseph, H. (. 2000). Substance misuse and related infectious diseases in a soup kitchen population. Substance Use & Misuse, 35 (4), 551-583
26. Maher, L., Li, J., Jalaludin, B., Chant, K. G., & Kaldor, J. M. (. 2007). High hepatitis C incidence in new injecting drug users: A policy failure? Australian and New Zealand Journal of Public Health, 31 (1), 30-35
27. Miller, C. L., Johnston, C., Spittal, P. M., Li, K., Laliberte, N., Montaner, J. S., & Schechter, M. T. (. 2002). Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology, 36 (3), 737-742
28. Neaigus, A., Gyarmathy, V. A., Miller, M., Frajzyngier, V., Zhao, M., Friedman, S. R., & Des Jarlais, D. C. (. 2007). Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug and Alcohol Dependence, 89 (2-3), 234-243
29. Paraskevis, D., Nikolopoulos, G., Fotiou, A., Tsiara, C., Paraskeva, D., Sypsa, V.,. Hatzakis, A. (. 2013). Economic recession and emergence of an HIV-1 outbreak among drug injectors in athens metropolitan area: A longitudinal study. PloS One, 8, e78941. doi: 10.1371/journal.pone.0078941
30. Pouget, E. R., Hagan, H., & Des Jarlais, D. C. (. 2012). Meta-Analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction, 107 (6), 1057-1065
31. Quan, V. M., Go, V. F., Nam le, V., Bergenstrom, A., Thuoc, N. P., Zenilman, J.,. Celentano, D. D. (. 2009). Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: A case-control study. AIDS Care, 21 (1), 7-16
32. Rachlis, B., Brouwer, K. C., Mills, E. J., Hayes, M., Kerr, T., & Hogg, R. S. (. 2007). Migration and transmission of blood-borne infections among injection drug users: Understanding the epidemiologic bridge. Drug and Alcohol Dependence, 90 (2-3), 107-119
33. Reyes, J. C., Robles, R. R., Colón, H. M., Matos, T. D., Finlinson, H. A., Marrero, C. A., & Shepard, E. W. (. 2005). Homelessness and HIV risk behaviors among drug injectors in Puerto Rico. Journal of Urban Health, 82, 446-455
34. Saigí, N., Espelt, A., Folch, C., Sarasa-Renedo, A., Castellano, Y., Majó, X., Meroño, M.,. Redan Study Group. (. 2014). Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones, 26, 69-76
35. Smyrnov, P., Broadhead, R. S., Datsenko, O., & Matiyash, O. (. 2012). Rejuvenating harm reduction projects for injection drug users: Ukraine's nationwide introduction of peer-driven interventions. International Journal of Drug Policy, 23, 141-147
36. Strathdee, S.A., Lozada, R., Pollini, R.A., Brouner, K.C., Mantsios, A., Abramovitz, D. A., Rhodes.,. Patterson, T.L. (. 2008). Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. Journal of Acquired Immune Deficiency Syndromes, 47, 369-376
37. Sysa, V., Paraskevis, D., Malliori, M., Nikopoulos, G.K., Panopoulos, A., Kantzanou, M., Katsoulidou, A.,. Hatzakis, A. (. 2015). Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece. American Journal of Public Health, 1, 196-204
38. Thiede, H., Hagan, H., Campbell, J. V., Strathdee, S. A., Bailey, S. L., Hudson, S. M.,. Team, D. S. (. 2007). Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug and Alcohol Dependence, 91 (Suppl 1), S39-47
39. Topp, L., Iversen, J., Baldry, E., & Maher, L. (. 2013). Housing instability among people who inject drugs: Results from the Australian needle and syringe program survey. Journal of Urban Health, 90 (4), 699-716
40. Tordable Merino, I., Sánchez SÃchez, A., Santos Sanz, S., García Vicario, M., & Redondo Martín, S. (2010).Trends in drug consumption among immigrants between 2004 and 2008. Gaceta Sanitaria/S.E.S.P.A.S, 24 (3), 200-203
41. Uusküla, A., Kals, M., Rajaleid, K., Abel, K., Talu, A., Rüütel, K.,. Des Jarlais, D. (. 2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: Need for large scale prevention programs. Journal of Public Health, 30 (2), 119-125
42. Wiessing, L., Likatavicius, G., Hedrich, D., Guarita, B., van de Laar, M. J., & Vicente, J. (. 2011). Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro surveillance, 16 (48), 20031. Retrieved from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20031
43. World Health Organisation (WHO). (. 1994). Multi-City Study on Drug Injecting and Risk of HIV Infection. Programme on Substance Abuse-Final Report. WHO/PSA/94.4. Geneva, Switzerland: Author